Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04209946 · ClinicalTrials.gov registry record · NA
Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants
A NA study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 180
- Enrollment target
NCT04209946: Completed NA study, sponsored by Sharp HealthCare.
NCT04209946 is a NA study that has completed, run by Sharp HealthCare. The registered enrollment target is 180 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04209946, a NA study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
Study Summary
This study is being conducted to determine whether prophylactic administration of surfactant by the Less Invasive Surfactant Administration (LISA) method reduces the need for mechanical ventilation in the first 72 hours of life when compared to early Continuous Positive Airway Pressure (CPAP) alone.
Interventions
- PROCEDURE Less Invasive Surfactant Administration LISA
- PROCEDURE Continuous Positive Airway Pressure CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2020-01-22 |
| Est. Completion | 2025-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04209946
The ClinicalTrials.gov registry entry for NCT04209946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Less Invasive Surfactant Administration LISA is the first listed.
NCT04209946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04209946 about?
NCT04209946 is a clinical study titled "Early Caffeine and LISA Compared to Caffeine and CPAP in Preterm Infants". This study is being conducted to determine whether prophylactic administration of surfactant by the Less Invasive Surfactant Administration (LISA) method reduces the need for mechanical ventilation in the first 72 hours of life when compared to early Continuous Positive Airway Pressure (CPAP) alone.
What is the current status of trial NCT04209946?
This trial is currently completed. It is a NA study. The enrollment target is 180 participants. The study started on 2020-01-22. Estimated completion is 2025-11-10.
What interventions are being tested in trial NCT04209946?
The interventions under investigation include: Less Invasive Surfactant Administration LISA (PROCEDURE), Continuous Positive Airway Pressure CPAP (PROCEDURE).
Who is sponsoring clinical trial NCT04209946?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.